- Genetic variants in IL-6/JAK/STAT3 pathway and the risk of CRC
Shuwei Wang et al, 2016, Tumor Biology CrossRef - Janus kinase 2 inhibition by Licochalcone B suppresses esophageal squamous cell carcinoma growth
Mengqiu Song et al, 2020, Phytotherapy Research CrossRef - Design, synthesis, biological activity evaluation of 3-(4-phenyl-1H-imidazol-2-yl)-1H-pyrazole derivatives as potent JAK 2/3 and aurora A/B kinases multi-targeted inhibitors
You-Guang Zheng et al, 2021, European Journal of Medicinal Chemistry CrossRef - Interleukin-6 and colorectal cancer development
I.А. Hromakova et al, 2021, Український радіологічний та онкологічний журнал CrossRef - Ganoderic acid A exerts antitumor activity against MDA‑MB‑231 human breast cancer cells by inhibiting the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway
Yuguang Yang et al, 2018, Oncology Letters CrossRef - Targeting STAT3 in cancer and autoimmune diseases
Tohid Gharibi et al, 2020, European Journal of Pharmacology CrossRef - STAT3 Inhibitors in Cancer: A Comprehensive Update
Uddalak Bharadwaj et al, 2016, STAT Inhibitors in Cancer CrossRef - Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling
Zhang-Bin Tan et al, 2019, Journal of Ethnopharmacology CrossRef - Expression level and potential target pathways of miR-1-3p in colorectal carcinoma based on 645�cases from 9 microarray datasets
Jie‑Yu Wang et al, 2018, Molecular Medicine Reports CrossRef - Targeting transcription factor STAT3 for cancer prevention and therapy
Edna Zhi Pei Chai et al, 2016, Pharmacology & Therapeutics CrossRef - Inflammatory genes are novel prognostic biomarkers for colorectal cancer
Hao Jiang et al, 2018, International Journal of Molecular Medicine CrossRef - Shmt2: A Stat3 Signaling New Player in Prostate Cancer Energy Metabolism
Ilaria Marrocco et al, 2019, Cells CrossRef - Effects of apigenin pretreatment against renal ischemia/reperfusion injury via activation of the JAK2/STAT3 pathway
Yang Liu et al, 2017, Biomedicine & Pharmacotherapy CrossRef - Fu-Zheng-Tong-Luo formula promotes autophagy and alleviates idiopathic pulmonary fibrosis by controlling the Janus kinase 2/signal transducer and activator of transcription 3 pathway
Xing Zhang et al, 2023, Journal of Ethnopharmacology CrossRef - Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics
Taiwo Adesoye et al, 2024, Cancers CrossRef - STAT3 pathway in cancers: Past, present, and future
Han‐Qi Wang et al, 2022, MedComm CrossRef - The Role of the JAK/STAT Signalling Pathway in Immunoregulation of Gastrointestinal Cancers
Kris Vaddi, 2017, Immunotherapy for Gastrointestinal Cancer CrossRef - 3-Deoxy-2β,16-dihydroxynagilactone E, a natural compound from Podocarpus nagi, preferentially inhibits JAK2/STAT3 signaling by allosterically interacting with the regulatory domain of JAK2 and induces apoptosis of cancer cells
Hui Shan et al, 2019, Acta Pharmacologica Sinica CrossRef